Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Korean Dermatological Association full text link Korean Dermatological Association Free PMC article
Full text links

Actions

Share

.2015 Oct;27(5):563-77.
doi: 10.5021/ad.2015.27.5.563. Epub 2015 Oct 2.

Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment

Affiliations

Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment

Jung Eun Kim et al. Ann Dermatol.2015 Oct.

Abstract

Background: Since the treatment guidelines for atopic dermatitis (AD) were released by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been several advances in AD management.

Objective: We aimed to establish updated evidence- and experience-based treatment guidelines for Korean AD.

Methods: We collected a database of references from relevant systematic AD reviews and guidelines regarding general AD management such as bathing and skin care, avoidance of exacerbating factors, education and psychosocial support, and the use of moisturizers and topical anti-inflammatory and antipruritic drugs. Evidence for each statement was graded and the strength of the recommendation for each statement classified. Thirty-nine KADA council members participated in three rounds of voting to establish an expert consensus of recommendations.

Results: Basic AD treatment includes proper bathing and skin care, avoidance of exacerbating factors, proper education and psychosocial support, and use of moisturizers. The regular use of moisturizer has a steroid-sparing effect and reduces relapse episodes. The short- and long-term use of topical corticosteroids and calcineurin inhibitors improves AD symptoms and should be encouraged to use in an active and proactive treatment. Wet-wrap therapy can be used for rapid recovery of acute exacerbation. Topical antipruritic drugs cannot be recommended for the treatment of AD.

Conclusion: This report provides up-to-date evidence- and experience-based treatment guidelines for AD regarding general management and topical treatment. In addition, the average agreement scores obtained by a panel of experts based on the Korean healthcare system and patient adherence are presented.

Keywords: Administration; Guideline; Therapeutics; topical.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Young Roh is a clinical trials investigator for Astellas and Novartis. Hyun Chang Ko is a clinical trials investigator for Astellas.

Figures

Fig. 1
Fig. 1. The fingertip unit (FTU) method is used in to determine the amount of topical corticosteroids (TCS) or calcineurin inhibitors to apply. The amount from the distal skin crease to the tip of an adult patient's index finger is equivalent to approximately 0.5 g TCS. 1 FTU generally covers the surface area of two palms.
See this image and copyright information in PMC

Similar articles

  • Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.
    Kim JE, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH, Park KY, Seo SJ, Bae JM, Choi EH, Suhr KB, Lee SC, Ko HC, Park YL, Son SW, Seo YJ, Lee YW, Cho SH, Park CW, Roh JY.Kim JE, et al.Ann Dermatol. 2015 Oct;27(5):578-92. doi: 10.5021/ad.2015.27.5.578. Epub 2015 Oct 2.Ann Dermatol. 2015.PMID:26512172Free PMC article.
  • Consensus Update for Systemic Treatment of Atopic Dermatitis.
    Lee JH, Kim JE, Park GH, Bae JM, Byun JY, Shin MK, Han TY, Hong SP, Jang YH, Kim HO, Na CH, Lew BL, Ahn J, Park CO, Seo YJ, Lee YW, Son SW, Choi EH, Park YL, Roh JY.Lee JH, et al.Ann Dermatol. 2021 Dec;33(6):497-514. doi: 10.5021/ad.2021.33.6.497. Epub 2021 Nov 4.Ann Dermatol. 2021.PMID:34858001Free PMC article.
  • A comparison of international management guidelines for atopic dermatitis.
    LePoidevin LM, Lee DE, Shi VY.LePoidevin LM, et al.Pediatr Dermatol. 2019 Jan;36(1):36-65. doi: 10.1111/pde.13678. Epub 2018 Oct 10.Pediatr Dermatol. 2019.PMID:30303557Review.
  • Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.
    Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS).Wollenberg A, et al.J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682. doi: 10.1111/jdv.14891.J Eur Acad Dermatol Venereol. 2018.PMID:29676534
  • Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
    Hussain Z, Sahudin S, Thu HE, Shuid AN, Bukhari SN, Kumolosasi E.Hussain Z, et al.Crit Rev Ther Drug Carrier Syst. 2016;33(3):213-263. doi: 10.1615/CritRevTherDrugCarrierSyst.2016015219.Crit Rev Ther Drug Carrier Syst. 2016.PMID:27910751Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Elias PM, Eichenfield LF, Fowler JF, Jr, Horowitz P, McLeod RP. Update on the structure and function of the skin barrier: atopic dermatitis as an exemplar of clinical implications. Semin Cutan Med Surg. 2013;32(2 Suppl 2):S21–S24. - PubMed
    1. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116–132. - PMC - PubMed
    1. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71:1218–1233. - PMC - PubMed
    1. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26:1045–1060. - PubMed
    1. Rubel D, Thirumoorthy T, Soebaryo RW, Weng SC, Gabriel TM, Villafuerte LL, et al. Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol. 2013;40:160–171. - PubMed

Related information

LinkOut - more resources

Full text links
Korean Dermatological Association full text link Korean Dermatological Association Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp